A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
A study to assess the efficacy and safety of Dato-DXd in the pre-chemotherapy setting for patients with metastatic HR-positive, HER2 IHC 0 breast cancer.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat w momencie badania kwalifikacyjnego
- •Rak piersi z receptorami hormonalnymi dodatnimi, rozprzestrzeniający się lub niemożliwy do operacji
- •Progresja choroby mimo terapii hormonalnej, która nie może być kontynuowana
- •Ogólny stan zdrowia pozwalający na normalne codzienne aktywności (ECOG 0-1)
- •Spodziewana długość życia co najmniej 12 tygodni
- •Dostarczona próbka nowotworu (nie starsza niż 6 tygodni) przed rozpoczęciem badania
- •Mierzalne lub ocenialne ogniska choroby widoczne w badaniach obrazowych
- •Wystarczająca funkcja narządów i składniki krwi w normie (hemoglobina, trombocyty, białe krwinki, funkcja wątroby i nerek)
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- May 12, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (40)
Research Site
Largo, United States
Research Site
Fort Wayne, United States
Research Site
Omaha, United States
Research Site
New York, United States
Research Site
Houston, United States
Research Site
Puyallup, United States
Research Site
Beijing, China
Research Site
Changsha, China
Research Site
Guangzhou, China
Research Site
Linyi, China
Research Site
Shandong, China
Research Site
Wuhan, China
Research Site
Zhengzhou, China
Research Site
Clermont-Ferrand, France
Research Site
La Roche-sur-Yon, France
Research Site
Montpellier, France
Research Site
Paris, France
Research Site
Pierre-Bénite, France
Research Site
Aviano, Italy
Research Site
Florence, Italy
Research Site
Meldola, Italy
Research Site
Milan, Italy
Research Site
Naples, Italy
Research Site
Roma, Italy
Research Site
Bukgu, South Korea
Research Site
Goyang-si, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
A Coruña, Spain
Research Site
Barcelona, Spain
Research Site
Granada, Spain
Research Site
Madrid, Spain
Research Site
Madrid, Spain
Research Site
Seville, Spain
Research Site
Valencia, Spain
Trial contact
AstraZeneca Clinical Study Information Center
Contact information from ClinicalTrials.gov. Contact in English.
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.